The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Infections with multidrug resistant (MDR) bacteria in hospital settings have substantial implications in terms of clinical and economic outcomes. However, due to clinical and methodological heterogeneity, estimates about the attributable economic and clinical effects of healthcare-associated infections (HAI) due to MDR microorganisms (MDR HAI) remain unclear. The objective was to review and synthesize the evidence on the impact of MDR HAI in adults on hospital costs, length of stay, and mortality at discharge. METHODS AND FINDINGS: Literature searches were conducted in PubMed/MEDLINE, and Google Scholar databases to select studies that evaluated the impact of MDR HAI on economic and clinical outcomes. Eligible studies were conducted in adults, in order to ensure homogeneity of populations, used propensity score matched cohorts or included explicit confounding control, and had confirmed antibiotic susceptibility testing. Risk of bias was evaluated, and effects were measured with ratios of means (ROM) for cost and length of stay, and risk ratios (RR) for mortality. A systematic search was performed on 14th March 2019, re-run on the 10th of June 2019 and extended the 3rd of September 2019. Small effect sizes were assessed by examination of funnel plots. Sixteen articles (6,122 patients with MDR HAI and 8,326 patients with non-MDR HAI) were included in the systematic review of which 12 articles assessed cost, 19 articles length of stay, and 14 mortality. Compared to susceptible infections, MDR HAI were associated with increased cost (ROM 1.33, 95%CI [1.15; 1.54]), prolonged length of stay (ROM 1.27, 95%CI [1.18; 1.37]), and excess in-hospital mortality (RR 1.61, 95%CI [1.36; 1.90]) in the random effects models. Risk of publication bias was only found to be significant for mortality, and overall study quality good. CONCLUSIONS: MDR HAI appears to be strongly associated with increases in direct cost, prolonged length of stay and increased mortality. However, further comprehensive studies in this setting are warranted. TRIAL REGISTRATION: PROSPERO (CRD42019126288).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
(2014) · Medical Entomology and Zoology · Cited by 17,633
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449 · cited 2×
“First, each included study must: i) have been published between 1st January 1980 - 3rd September 2019 in English, ii) attempt to estimate the direct impact of MDR (MDR was defined in accordance to the current available interim expert proposal[20]) HAIs on either clinical or economic outcomes using original data with a…”
BackgroundMethodLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., Colomb-Cotinat, M., Kretzschmar, M. E., Devleesschauwer, B., Cecchini, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30605-4 · Cited by 2,945
Self-citation(2016) · Cited by 2,888
IntHout, J., Ioannidis, J. P., & Borm, G. F. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-25 · Cited by 2,419 · cited 1×
“Given the clinical heterogeneity present in the analysis, a random effects model with the Hartung-Knapp-Sidik-Jonkman method was chosen as the primary estimation method[30].”
MethodPlea for routinely presenting prediction intervals in meta-analysis.
IntHout, J., Ioannidis, J. P. A., Rovers, M. M., & Goeman, J. J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010247 · Cited by 2,264
Kirkland, K. B., Briggs, J. P., Trivette, S. L., Wilkinson, W. E., & Sexton, D. J. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501572 · Cited by 1,714
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
The negative impact of antibiotic resistance
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.002 · Cited by 870
Multiple molecular mechanisms for multidrug resistance transporters
Higgins, C. F. (2007) · Nature · doi:10.1038/nature05630 · Cited by 860
Kurth, T., Walker, A. M., Glynn, R. J., Chan, K. A., Gaziano, J. M., Berger, K., & Robins, J. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj047 · Cited by 730
Multidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605630 · Cited by 705
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Propensity Score Matching: A Statistical Method
Kane, L. T., Fang, T., Galetta, M. S., Goyal, D. K. C., Nicholson, K. J., Kepler, C. K., Vaccaro, A. R., & Schroeder, G. D. (2020) · Clinical Spine Surgery: A Spine Publication · doi:10.1097/bsd.0000000000000932 · Cited by 603
Bacterial Resistance: Origins, Epidemiology, and Impact
Livermore, D. M. (2003) · Clinical Infectious Diseases · doi:10.1086/344654 · Cited by 586
Antimicrobial resistance—a threat to the world’s sustainable development
Jasovský, D., Littmann, J., Zorzet, A., & Cars, O. (2016) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2016.1195900 · Cited by 442
Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers
Hartling, L., Milne, A., Hamm, M. P., Vandermeer, B., Ansari, M., Tsertsvadze, A., & Dryden, D. M. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.03.003 · Cited by 436
Mueller, M., D’Addario, M., Egger, M., Cevallos, M., Dekkers, O., Mugglin, C., & Scott, P. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0495-9 · Cited by 400
Economic burden of healthcare-associated infections: an American perspective
Stone, P. W. (2009) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.09.53 · Cited by 394
Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa
Carmeli, Y., Troillet, N., Karchmer, A. W., & Samore, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1127 · Cited by 363
Mauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T., & Bosso, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01041-09 · Cited by 360
Nathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
Friedrich, J. O., Adhikari, N. K., & Beyene, J. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-32 · Cited by 327
Misunderstandings about Q and ‘Cochran's Q test' in meta‐analysis
Hoaglin, D. C. (2016) · Statistics in Medicine · doi:10.1002/sim.6632 · Cited by 310
Micek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
Neidell, M. J., Cohen, B., Furuya, Y., Hill, J., Jeon, C. Y., Glied, S., & Larson, E. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis552 · Cited by 223
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Puchter, L., Chaberny, I. F., Schwab, F., Vonberg, R., Bange, F., & Ebadi, E. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0291-z · Cited by 153
(2015) · doi:10.1016/j.jinf.2014.10.004 · Cited by 143
Kopp, B. J., Nix, D. E., & Armstrong, E. P. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e028 · Cited by 137
Sidwell, K. (1993) · The Journal of Hellenic Studies · doi:10.2307/632432 · Cited by 121
Measuring the impact of multidrug resistance in nosocomial infection
Blot, S. I., Depuydt, P. O., Vandewoude, K., & Bacquer, D. D. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32818be6f7 · Cited by 117
Depuydt, P. O., Vandijck, D. M., Bekaert, M., Decruyenaere, J. M. A., Blot, S. I., Vogelaers, D., & Benoît, D. (2008) · Critical Care · doi:10.1186/cc7119 · Cited by 116
Fernández-Barat, L., Ferrer, M., De Rosa, F., Gabarrús, A., Esperatti, M., Terraneo, S., Rinaudo, M., Li Bassi, G., & Torres, A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2016.11.008 · Cited by 99
Resch, A., Wilke, M. H., & Fink, C. (2008) · The European Journal of Health Economics · doi:10.1007/s10198-008-0132-3 · Cited by 80
The power of the standard test for the presence of heterogeneity in meta-analysis
Jackson, D. (2005) · Statistics in Medicine · doi:10.1002/sim.2481 · Cited by 78
Pelz, R. K., Lipsett, P. A., Swoboda, S. M., Diener‐West, M., Powe, N. R., Brower, R. G., Perl, T. M., Hammond, J., & Hendrix, C. W. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1276-8 · Cited by 66
Riu, M., Chiarello, P., Terradas, R., Sala, M., García-Alzorriz, E., Castells, X., Grau, S., & Cots, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153076 · Cited by 65
Nosocomial MRSA Infection in Vascular Surgery Patients: Impact on Patient Outcome
Cowie, S. E., Ma, I. W. Y., Lee, S. K., Smith, R. M., & Hsiang, Y. N. (2005) · Vascular and Endovascular Surgery · doi:10.1177/153857440503900404 · Cited by 56
(2001) · Clinical Risk · doi:10.1258/1356262011928644 · Cited by 55
Magira, E. E., Islam, S., & Niederman, M. S. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.07.006 · Cited by 46
Bonnet, V., Dupont, H., Glorion, S., Aupée, M., Kipnis, É., Gérard, J., Hanouz, J., & Fischer, M.-O. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.01.011 · Cited by 38
The impact of multidrug resistance on outcomes in ventilator-associated pneumonia
Tedja, R. M., Nowacki, A. S., Fraser, T. G., Fatica, C. A., Griffiths, L. A., Gordon, S. M., Isada, C. M., & van Duin, D. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.12.009 · Cited by 32
Chen, Z., Xu, Z., Wu, H., Chen, L., Gao, S., & Chen, Y. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2018.10.025 · Cited by 18
Notes on Subgroup Analyses and Meta‐Regression
(2009) · Introduction to Meta‐Analysis · doi:10.1002/9780470743386.ch21 · Cited by 13
Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures
Nelson, R. E., Stevens, V. W., Jones, M., Khader, K., Schweizer, M. L., Perencevich, E. N., Rubin, M. A., & Samore, M. H. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00462-18 · Cited by 9
Cited by
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 474
Metadata
- Authors
- Serra-Burriel, M., Keys, M., Campillo-Artero, C., Agodi, A., Barchitta, M., Gikas, A., Palos, C., & López-Casasnovas, G.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-01-10
- Volume
- 15
- Issue
- 1
- Pages
- e0227139
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2998893026
- Cited by
- 259
- References
- 57
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.